NCT03731949

Brief Summary

Placenta grows with advancing gestational age amonitoring of placental growth is important in pregnancy evaluation

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

November 16, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2019

Completed
Last Updated

January 10, 2019

Status Verified

January 1, 2019

Enrollment Period

7 months

First QC Date

November 4, 2018

Last Update Submit

January 8, 2019

Conditions

Placenta Diseases

Outcome Measures

Primary Outcomes (1)

  • the volume of every placenta at the given time of scan

    volume of placenta that will increase with time

    within 2 months

Interventions

UltrasonographyDIAGNOSTIC_TEST

Ultrasonography to assess placental volume

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant women
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

* pregnant ladies between 20 - 40 years old * ladies pregnant from 14 weeks till term

You may qualify if:

  • pregnant ladies between 20 - 40 years old
  • ladies pregnant from 14 weeks till term

You may not qualify if:

  • pregnant ladies in first trimester

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah and Kasralainy hospital

Giza, Egypt

RECRUITING

MeSH Terms

Conditions

Placenta Diseases

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy

    Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mahmoud Alalfy

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
4 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Study Record Dates

First Submitted

November 4, 2018

First Posted

November 6, 2018

Study Start

November 16, 2018

Primary Completion

June 1, 2019

Study Completion

July 5, 2019

Last Updated

January 10, 2019

Record last verified: 2019-01

Locations

EG(1)